Stage IIIA Breast Cancer (DBCOND0028774)

Identifiers

Synonyms
Breast Cancer Stage IIIA

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNo drug interventionstreatment2recruiting
NCT03723863
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availableterminated
NCT03202446
Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancertreatment3terminated
NCT01723943
Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00019643
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast CancerNo drug interventionsNot AvailableNot Availableterminated
NCT01043003
Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or CaregiversNo drug interventionssupportive_careNot Availablecompleted
NCT01959490
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancerbasic_science2completed
NCT02370264
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast CancerNo drug interventionssupportive_careNot Availableterminated
NCT01869764
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancertreatment2completed
NCT01672684
Phase I: At-Home Support for Rural Women Using Group Video CallingNo drug interventionssupportive_care1completed
NCT01941784
Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00450879
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgerytreatment1terminated
NCT01372579
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patientstreatment2unknown_status
NCT02168179
KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT01628887
Feasibility of a Supportive Education Program for Latina Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availableterminated
NCT01730833
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancertreatment2active_not_recruiting
NCT01238133
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancertreatment1terminated
NCT02002533
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00436254
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancertreatment1active_not_recruiting
NCT02235051
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT02060253
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancertreatment1completed
NCT02827877
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancertreatment2active_not_recruiting
NCT02454777
High-Intensity Interval Training for Stage I-III Breast Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT02370277
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumorstreatment1terminated
NCT02699983
eHealth Weight Loss Program in African American Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT01292083
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgerytreatmentNot Availablewithdrawn
NCT01394211
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancertreatment2terminated
NCT01558778
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNo drug interventionssupportive_careNot Availablewithdrawn
NCT00146588
Cytoxan, Epirubicin and Capecitabine in Women With Breast CancertreatmentNot Availablecompleted
NCT03971409
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancertreatment2recruiting
NCT00986609
MUC1 Vaccine for Triple-negative Breast Cancerother0completed
NCT01931709
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast CancerNo drug interventionsdiagnosticNot Availableterminated
NCT03566485
Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancertreatment1 / 2terminated
NCT00416715
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancersupportive_care2completed
NCT01013337
Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint PainNo drug interventionssupportive_careNot Availablecompleted
NCT01729832
Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT01632332
Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancertreatment1completed
NCT02273752
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancertreatment2terminated
NCT00070252
Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancertreatment1 / 2completed
NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancertreatment2active_not_recruiting
NCT01050075
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving PaclitaxelNo drug interventionssupportive_careNot Availableterminated
NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapydiagnostic1 / 2completed
NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumorstreatment1completed
NCT03091842
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT01824836
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)supportive_careNot Availableactive_not_recruiting
NCT00080613
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancertreatment2withdrawn
NCT00378313
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancertreatment2completed
NCT01754519
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing SurgeryNo drug interventionstreatment2terminated
NCT03128619
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancertreatment1terminated
NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutationstreatment0completed
NCT01606241
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancertreatment1completed
NCT01897441
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast CancertreatmentNot Availableactive_not_recruiting
NCT01208441
RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancertreatment1terminated
NCT00063934
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancertreatment1 / 2terminated
NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancertreatment1completed
NCT03556358
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With HerceptinĀ® in HER2+ Early Breast Cancertreatment3completed
NCT03139435
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03050463
Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01368263
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancertreatment2terminated
NCT01928186
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerdiagnosticNot Availablecompleted
NCT03198286
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01417286
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerNo drug interventionstreatment2completed
NCT01319539
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast CancerNo drug interventionstreatment2terminated
NCT02702830
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01881048
Window of Opportunity Study Targeting the Inflammatory Milieutreatment0active_not_recruiting
NCT03364348
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancertreatment1completed
NCT03102866
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumorstreatment1completed
NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumorstreatment1completed
NCT01750073
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancertreatment2active_not_recruiting
NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapydiagnostic2completed
NCT02445391
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapytreatment3active_not_recruiting
NCT01982591
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT04109391
Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03treatment3completed
NCT00119262
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancertreatment2completed
NCT00679029
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancertreatment2terminated
NCT00513292
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgerytreatment3completed
NCT03039140
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT01159067
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overloadsupportive_care2terminated
NCT00470301
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancertreatment1 / 2completed
NCT02780401
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remissionprevention1active_not_recruiting
NCT01051401
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancertreatment1terminated
NCT00060372
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancertreatment1completed
NCT02957968
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Catreatment2active_not_recruiting
NCT03284346
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availableterminated
NCT01493310
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancertreatment1completed
NCT02038010
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Txtreatment1completed
NCT00408681
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplantsupportive_careNot Availablecompleted
NCT00049114
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancertreatment2completed
NCT02566408
Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical ActivityNo drug interventionssupportive_careNot Availablecompleted
NCT01776008
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancertreatment2terminated
NCT00516243
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancertreatment1completed
NCT01868503
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancertreatment2terminated
NCT00066690
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancertreatment3active_not_recruiting
NCT00194779
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgerytreatment2completed
NCT02415387
Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancerbasic_science0completed
NCT01113554
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer SurvivorsNo drug interventionstreatmentNot Availablecompleted
NCT01487954
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation TherapyNo drug interventionssupportive_care2completed
NCT02157051
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast CancerNo drug interventionstreatment1active_not_recruiting
NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast CancerNo drug interventionstreatmentNot Availableterminated
NCT01478477
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or LetrozoleNo drug interventionspreventionNot Availablecompleted
NCT00572728
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancerdiagnostic2completed
NCT01697293
PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancertreatment1 / 2terminated
NCT01355393
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancertreatment1 / 2completed
NCT03188393
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryNo drug interventionsother2suspended
NCT01953588
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgerytreatment3active_not_recruiting
NCT00407888
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgerytreatment2completed
NCT01688609
Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancertreatment2completed
NCT01712815
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast CancerNo drug interventionsdiagnosticNot Availableterminated
NCT01234532
Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgerytreatment2terminated
NCT01293032
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancertreatmentNot Availablecompleted
NCT02203552
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancerprevention2unknown_status
NCT01219075
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast CancerNo drug interventionspreventionNot Availablecompleted
NCT03061175
Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyNo drug interventionssupportive_careNot Availablecompleted
NCT03414970
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerNo drug interventionssupportive_care3active_not_recruiting
NCT02269670
Phase II Study of Everolimus Beyond Progressiontreatment2terminated
NCT01151449
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancertreatment2terminated
NCT01243541
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelNo drug interventionssupportive_careNot Availableterminated
NCT01483196
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT02315196
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancertreatment2active_not_recruiting
NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)No drug interventionshealth_services_researchNot Availablecompleted
NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumorstreatment1completed
NCT02662335
Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT01818063
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancertreatment2completed
NCT00343863
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancersupportive_careNot Availablecompleted
NCT03025139
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)No drug interventionssupportive_careNot Availableunknown_status
NCT03044730
Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgerytreatment2unknown_status
NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgerytreatment2recruiting
NCT01695057
Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast CancertreatmentNot Availablewithdrawn
NCT00618657
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Settingtreatment2completed
NCT00070057
Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancertreatment1completed
NCT01525966
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancertreatment2active_not_recruiting
NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neutreatment1completed
NCT01140282
Exercise Program for Early Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00016276
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancertreatment3terminated
NCT02400060
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT01901094
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyNo drug interventionstreatment3active_not_recruiting
NCT02677389
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinNo drug interventionssupportive_careNot Availablecompleted
NCT01391689
Diindolylmethane in Treating Patients With Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT00194792
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancertreatment2terminated
NCT01194440
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptomssupportive_care2completed
NCT02488967
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancertreatment3active_not_recruiting
NCT00425672
ONTAKĀ® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatmenttreatment1 / 2completed
NCT03112668
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersNo drug interventionssupportive_careNot Availablecompleted
NCT00795769
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplantsupportive_care2completed
NCT00513695
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancertreatment2completed
NCT02432950
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01849250
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivorsprevention2completed
NCT02023008
Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation TherapyNo drug interventionssupportive_careNot Availableterminated
NCT01755208
Light-Scattering Spectroscopy for Detection of Breast CancerNo drug interventionsdiagnosticNot Availableterminated
NCT02414646
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancertreatment2active_not_recruiting
NCT03156309
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remissionprevention1recruiting